Arrail Group Secures $90 Million Series D Funding Led by Goldman Sachs and Hillhouse Capital

VCBeat (WeChat: vcbeat) has learned that Arrail Group announced today the completion of a $90 million Series D financing round, jointly invested by Goldman Sachs Group and Hillhouse Capital. China Renaissance served as the exclusive financial advisor in this financing transaction.

Following the completion of the financing, Arrail Group will further establish and refine its development strategy, and announce the launch of its “1,000-Clinic Plan,” which is expected to be implemented over a period of 5–8 years.Established over 1,000 clinics and hospitals across China, dedicated to promoting and popularizing professional, high-quality mid-to-high-end oral care services.

Starting from its first clinic located in the Beijing International Building, 18 years of dedication have seen Arrail grow to operate in 14 major cities across China84 Directly Operated Clinics, 4 Dental Hospitals, and a high-end dental care chain with nearly 2,000 employees.

Currently, Arrail Group has“Real” and “Rite” brands, with operations spanning Beijing, Shanghai, Shenzhen, Guangzhou, Hangzhou, Xiamen, Tianjin, Chengdu, Chongqing, Xi’an, Qingdao, Ningbo, Changsha, Jinan, Wuxi, and other cities, having cumulatively served over 5 million patient visits.

In terms of service, each Arrail Dental clinic is equipped withMedical Service System of General Practitioners and Specialists, with a comprehensive referral and consultation system, it adopts internationally advanced medical management models and has established an institutionalized and normalized medical quality management and supervision system.

Reporters learned that each Arrail Dental clinic is staffed with general practitioners, and Arrail employs internationally advanced dental equipment and materials, having introducedSwedish NOBEL GUIDE Dental Implant Technology. Its material selection and design philosophy for aesthetic restorative treatments are fully aligned with international standards, ensuring optimal post-treatment outcomes. The introduced Siemens SIRONA series X-ray machines feature high precision coefficients, offering enhanced safety compared to similar products and effectively reducing radiation hazards.

Arrail Dental strictly adheres to the sterilization standards of the American Dental Association (ADA) to prevent cross-infection. All clinics are equipped with sterilization rooms and aseptic rooms, and use ultraviolet germicidal lamps for air disinfection.

In terms of medical talent reserves, Arrail Group has assembled professionals from prestigious domestic and international institutions, including the UCL Eastman Dental Institute at University College London, Peking University School of Stomatology, and West China School of Stomatology of Sichuan University. More than 60% of these professionals hold master’s or doctoral degrees, and some physicians have served as visiting scholars at the University of Pennsylvania School of Dental Medicine.

As the segment with the strongest consumer attributes and the highest degree of marketization, the dental industry has long entered an era of fierce competition for market share, especiallyHigh-margin services such as dental implants and orthodonticsGrowing audience acceptance has also drawn the attention of capital markets.

In 2010, Arrail Group received a $20 million investment from Kleiner Perkins and Qiming Venture Partners. In 2011, TPF Capital joined Kleiner Perkins and Qiming Venture Partners in a follow-on investment, bringing the total amount to $40 million. In April 2014, Arrail successfully secured Series C financing led by New Horizon Capital, with a total investment of $70 million. Upon completion of the Series D financing,Total Financing Reaches $220 Million。

Driven by the overall consumption upgrade in China and the rising health awareness among the middle class, oral healthcare services—particularly those provided by privately-run institutions—have vast market potential, emerging as a highly promising niche within the medical sector.

Regarding this financing round, Zou Qifang, Founder and President of Arrail Group, stated, “The current penetration rate of dentists in China is relatively low. As domestic residents’ incomes rise, greater importance will be attached to oral healthcare. Given China’s large population base, this will evolve into a trillion-yuan market in the future.”With cutting-edge dental medical technology, a top-tier team of physicians, and robust customer relationship management"As a seasoned pioneer in private healthcare, Arrail Group will continue to stride forward in this direction."

“Per capita income in China continues to rise, and so will the demand for high-quality medical services,” said Wanlin Liu, Managing Director at Goldman Sachs.The Future Chinese High-End Dental Care Service Market Holds Significant Growth Potential。”

Yi Nuoqing, Partner at Hillhouse Capital Group, also stated, “Hillhouse has always closely monitored and maintained a positive outlook on the development of the healthcare industry. Moving forward, Hillhouse will fully leverage its extensive investment experience accumulated over the years to actively support Arrail in further strengthening its advanced medical management and service systems, thereby delivering considerate, high-quality professional services to a broader population.”

As the exclusive financial advisor for this transaction, China Renaissance has accompanied Arrail Group from its Series A financing in 2010 all the way through to its Series D round, witnessing Arrail’s evolution from its first dental clinic into today’s leader in China’s dental medical services sector.

Since its inception, Arrail Group has positioned itself as a mid-to-high-end brand in the private dental clinic sector. Established in 1999, it has amassed an extensive medical case database within the industry. Through a comprehensive medical quality control system—including case discussions, complex case reporting, case screening, and multidisciplinary consultations—Arrail ensures that patients receive satisfactory treatment plans featuring minimally invasive, comfortable, and personalized care. Furthermore, Arrail has partnered with over 40 domestic and international insurance providers to establish a direct billing service system.